Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.42
-0.20 (-3.02%)
At close: Jul 11, 2025, 4:00 PM
6.41
-0.01 (-0.16%)
After-hours: Jul 11, 2025, 7:47 PM EDT
Bausch Health Companies Employees
Bausch Health Companies had 20,700 employees as of December 31, 2024. The number of employees increased by 430 or 2.12% compared to the previous year.
Employees
20,700
Change (1Y)
430
Growth (1Y)
2.12%
Revenue / Employee
$470,097
Profits / Employee
-$1,932
Market Cap
2.37B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20,700 | 430 | 2.12% |
| Dec 31, 2023 | 20,270 | 370 | 1.86% |
| Dec 31, 2022 | 19,900 | 300 | 1.53% |
| Dec 31, 2021 | 19,600 | -2,000 | -9.26% |
| Dec 31, 2020 | 21,600 | -100 | -0.46% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BHC News
- 2 days ago - CORRECTING and REPLACING: Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Nova Scotia and Two Federal Programs - Accesswire
- 2 days ago - Bausch Health Appoints New Chief Accounting Officer - Accesswire
- 3 days ago - Bausch Health, Canada Inc. Treatment for Acne Vulgaris, (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel), Now Available Through Public Drug Plans of Ontario, Quebec and Two Federal Programs - Accesswire
- 5 days ago - Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - Accesswire
- 10 days ago - Bausch Health to Announce Second Quarter 2025 Results on July 30 - Accesswire
- 16 days ago - Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility - Business Wire
- 20 days ago - A Billionaire Trump Supporter Is Buying These Two Stocks - Barrons
- 24 days ago - Bausch Health Shares Rise as Nonexecutive Chairperson Paulson Buys $21.2M in Shares - Market Watch